The anti-VLA-4 antibody natalizumab induces erythroblastaemia in the majority of the treated patients with multiple sclerosis. Robier C, Amouzadeh-Ghadikolai O, Bregant C, Diez J, Melinz K, Neubauer M, Quasthoff S Mult Scler. 2014 Feb 3. PMID: 24493472. Abstract CommentRecommendBookmarkWatch